Literature DB >> 15545082

The design and exogenous delivery of siRNA for post-transcriptional gene silencing.

Ian R Gilmore1, Stephen P Fox, Andrew J Hollins, Muhammad Sohail, Saghir Akhtar.   

Abstract

RNA interference (RNAi) is a natural cellular process that effects post-transcriptional gene silencing in eukaryotic systems. Small interfering RNA (siRNA) molecules are the key intermediaries in this process which when exogenously administered can inhibit or "silence" the expression of any given target gene. Thus, siRNA molecules hold great promise as biological tools and as potential therapeutic agents for targeted inhibition of disease-causing genes. However, key challenges to the effective and widespread use of these polyanionic, macromolecular duplexes of RNA are their appropriate design and efficient delivery to cells in vitro and in vivo. This review highlights the current strategies used in the design of effective siRNA molecules and also summarises the main strategies being considered for the exogenous delivery of siRNA for both in vitro and in vivo applications.

Mesh:

Substances:

Year:  2004        PMID: 15545082     DOI: 10.1080/10611860400006257

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  14 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.

Authors:  Olivia M Merkel; Meredith A Mintzer; Damiano Librizzi; Olga Samsonova; Tanja Dicke; Brian Sproat; Holger Garn; Peter J Barth; Eric E Simanek; Thomas Kissel
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 3.  Nonviral delivery of synthetic siRNAs in vivo.

Authors:  Saghir Akhtar; Ibrahim F Benter
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 4.  Efficient siRNA delivery with non-viral polymeric vehicles.

Authors:  Won Jong Kim; Sung Wan Kim
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 5.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

Review 6.  Lipid-based vectors for siRNA delivery.

Authors:  Shubiao Zhang; Defu Zhi; Leaf Huang
Journal:  J Drug Target       Date:  2012-09-20       Impact factor: 5.121

Review 7.  Nonviral methods for siRNA delivery.

Authors:  Kun Gao; Leaf Huang
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

8.  Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase.

Authors:  Gro F Flatekval; Mouldy Sioud
Journal:  Immunology       Date:  2009-03-23       Impact factor: 7.397

Review 9.  Functional polymers of gene delivery for treatment of myocardial infarct.

Authors:  Young-Wook Won; David A Bull; Sung Wan Kim
Journal:  J Control Release       Date:  2014-07-27       Impact factor: 9.776

10.  MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity.

Authors:  John J Turner; Simon W Jones; Sterghios A Moschos; Mark A Lindsay; Michael J Gait
Journal:  Mol Biosyst       Date:  2006-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.